|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.99 USD | -0.58% |
|
+0.24% | +1.92% |
| 06:35pm | BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany | MT |
| 06:14pm | BioMarin Pharmaceutical Sues Ascendis Pharma for Patent Infringement in Germany | MT |
| Capitalization | 1.28TCr 1.26TCr 1.18TCr 1.06TCr 1.85TCr 1,11300Cr 2.09TCr 14TCr 5.37TCr 46TCr 4.82TCr 4.72TCr 2,02500Cr | P/E ratio 2024 * |
33.4x | P/E ratio 2025 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.21TCr 1.19TCr 1.11TCr 997.68Cr 1.75TCr 1,05200Cr 1.97TCr 14TCr 5.08TCr 43TCr 4.55TCr 4.46TCr 1,91200Cr | EV / Sales 2024 * |
4.31x | EV / Sales 2025 * | 3.64x |
| Free-Float |
99.12% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioMarin Pharmaceutical Inc.
More recommendations
More press releases
More news
| 1 day | -0.58% | ||
| 1 week | +0.24% | ||
| Current month | +1.92% | ||
| 1 month | +1.10% | ||
| 3 months | -4.78% | ||
| 6 months | -21.21% | ||
| Current year | +1.92% |
1 week
65.95
69.70
1 month
63.9369.70
Current year
65.8669.70
1 year
61.1594.85
3 years
61.15117.77
5 years
61.15131.95
10 years
61.15151.75
| Director | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 01/12/2023 |
Brian Mueller
DFI | Director of Finance/CFO | 51 | 29/01/2020 |
Philip Lo Scalzo
CMP | Compliance Officer | - | 22/11/2012 |
| Manager | Title | Age | Since |
|---|---|---|---|
Elaine Heron
BRD | Director/Board Member | 78 | 01/07/2002 |
Randy Meier
CHM | Chairman | 66 | 01/12/2023 |
David Pyott
BRD | Director/Board Member | 71 | 04/01/2016 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.45% | 1 M€ | 0.00% | - | |
| 1.79% | 0 M€ | 0.00% | - | |
| 1.59% | 0 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.58% | +0.24% | -28.22% | -23.96% | 1.28TCr | ||
| -1.79% | -1.21% | -3.58% | -1.11% | 8.48TCr | ||
| +1.20% | +7.66% | +36.02% | +18.09% | 4.83TCr | ||
| -1.97% | +0.21% | +126.98% | +106.31% | 3.79TCr | ||
| +0.91% | -1.33% | -39.47% | -33.35% | 2.17TCr | ||
| +2.59% | +3.94% | +15.35% | -1.70% | 1.36TCr | ||
| +0.87% | -3.13% | -6.72% | -37.82% | 1.17TCr | ||
| -3.39% | -6.12% | +215.40% | +421.51% | 1.12TCr | ||
| +34.07% | +51.92% | +91.67% | +220.22% | 1.01TCr | ||
| +2.43% | +0.63% | +10.09% | +77.73% | 957.35Cr | ||
| Average | +3.56% | +1.01% | +41.75% | +74.59% | 2.62TCr | |
| Weighted average by Cap. | +0.90% | +1.13% | +32.82% | +41.99% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 281.56Cr 276.04Cr 258.82Cr 231.6Cr 405.8Cr 24TCr 457.59Cr 3.18TCr 1.18TCr 9.99TCr 1.06TCr 1.03TCr 44TCr | 310.87Cr 304.77Cr 285.75Cr 255.7Cr 448.04Cr 27TCr 505.22Cr 3.51TCr 1.3TCr 11TCr 1.17TCr 1.14TCr 49TCr |
| Net income | 40Cr 39Cr 36Cr 33Cr 57Cr 3.44TCr 64Cr 447.79Cr 166.06Cr 1.41TCr 148.99Cr 145.78Cr 6.26TCr | 60Cr 59Cr 55Cr 49Cr 86Cr 5.18TCr 97Cr 674.74Cr 250.23Cr 2.12TCr 224.5Cr 219.66Cr 9.43TCr |
| Net Debt | -71Cr -70Cr -65Cr -59Cr -102.65Cr -6.17TCr -115.75Cr -803.62Cr -298.02Cr -2.53TCr -267.38Cr -261.61Cr -11TCr | -152.68Cr -149.69Cr -140.35Cr -125.59Cr -220.05Cr -13TCr -248.14Cr -1.72TCr -638.87Cr -5.42TCr -573.18Cr -560.82Cr -24TCr |
More financial data
* Estimated data
Employees
3,401
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/25/14 | 66.99 $ | -0.58% | 1,181,341 |
| 10/25/10 | 67.38 $ | -1.46% | 1,227,980 |
| 08/25/08 | 68.38 $ | +0.71% | 1,465,862 |
| 07/25/07 | 67.90 $ | +1.24% | 1,349,377 |
| 06/25/06 | 67.07 $ | +0.36% | 1,030,612 |
Delayed Quote Nasdaq, January 14, 2025 at 02:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
67.38USD
Average target price
97.16USD
Spread / Average Target
+44.20%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMRN Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition